AVKARE Inc. has voluntarily recalled 8,644 bottles of Ranitidine Hydrochloride Capsules (150 mg and 300 mg) because tests found an impurity called N-nitrosodimethylamine (NDMA). These prescription medications are used to treat and prevent heartburn and stomach ulcers. The recall affects specific lot numbers sold in 500-count bottles across Colorado and Missouri. Consumers using these medications should contact their healthcare provider to discuss alternative treatments before stopping their medication.
The medication contains NDMA, which is classified as a probable human carcinogen based on laboratory testing. This impurity may increase the risk of cancer over long-term exposure, though no immediate adverse health events have been reported for this specific recall.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.